Is cyclooxygenase-2 the alpha and the omega in cancer?
Open Access
- 1 June 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (11), 1511-1513
- https://doi.org/10.1172/jci10241
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Host cyclooxygenase-2 modulates carcinoma growthJournal of Clinical Investigation, 2000
- Cyclooxygenase-2 and carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2000
- Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.2000
- Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healingNature Medicine, 1999
- Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.1999
- Peroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial CellsJournal of Biological Chemistry, 1999
- The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the ratCurrent Eye Research, 1999
- Landscaping the Cancer TerrainScience, 1998
- Prostaglandins Induce Vascular Endothelial Growth Factor in a Human Monocytic Cell Line and Rat Lungs via cAMPAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992